Gilead names Meyers EVP worldwide commercial operations

FOSTER CITY, Calif. — Gilead Sciences on Thursday announced the promotion of James Meyers to the position of EVP worldwide commercial operations. In the new position, Meyers, who has been with Gilead since 1996, will be responsible for all North American, European and Japanese business operations and will become an officer of the company and a member of its senior leadership team. 

 

Meyers joined Gilead as a regional sales director and has been the company’s SVP North American commercial operations since 2007. During his 20 years at Gilead, he has spearheaded the launch of various products for HIV, oncology, cardiovascular, respiratory and liver diseases. Before joining the company, held sales, training, marketing and management positions at Zeneca Pharmaceuticals and Astra USA. 

 

“Jim has demonstrated a remarkable ability to navigate the complexities of commercial operations, ensuring we reach diverse audiences with information about Gilead’s medicines and ultimately that we make those medicines accessible to people in need,” said Kevin Young CBE, Chief Operating Officer, Gilead Sciences. “I am confident that as Gilead’s portfolio of products continues to grow, Jim’s leadership and exceptional track record make him ideally suited to lead our global commercial organization.”